Trial intelligence / Profile preview

Docetaxel Plus Carboplatin in HRPC

NCT00675545Phase 2Completed

Sponsor
National University Hospital
Start
May 2007
Primary completion
May 2010
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of carboplatin in prostate cancer (PCa), sponsored by National University Hospital. Started May 2007; status: completed.

02

Drugs

carboplatin
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00675545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00675545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call